| For: | Ismaili N. Shifting paradigm in locally advanced resectable gastric and gastroesophageal junction cancers. World J Gastrointest Oncol 2026; 18(2): 113150 [PMID: 41695924 DOI: 10.4251/wjgo.v18.i2.113150] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v18/i2/113150.htm |
| Number | Citing Articles |
| 1 |
Nabil Ismaili. Rethinking biomarker strategy in gastric cancer immunotherapy: from tumor to host. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1847526
|
| 2 |
Nabil Ismaili. Practice-Changing Trials in Gastrointestinal Cancers at ASCO 2025: A Critical Review and Clinical Context. Cancer Investigation 2026; 44(6) doi: 10.1080/07357907.2026.2654136
|